Tuberculous meningitis diagnosis and treatment: classic approaches and high-throughput pathways
Author:
Open Access
- 10 January 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 15, 1543009
Abstract
Tuberculous meningitis (TBM), a severe form of non-purulent meningitis caused by Mycobacterium tuberculosis (Mtb), is the most critical extrapulmonary tuberculosis (TB) manifestation, with a 30–40% mortality rate despite available treatment. The absence of distinctive clinical symptoms and effective diagnostic tools complicates early detection. Recent advancements in nucleic acid detection, genomics, metabolomics, and proteomics have led to novel diagnostic approaches, improving sensitivity and specificity. This review focuses on nucleic acid-based methods, including Xpert Ultra, metagenomic next-generation sequencing (mNGS), and single-cell sequencing of whole brain Tissue, alongside the diagnostic potential of metabolomic and proteomic biomarkers. By evaluating the technical features, diagnostic accuracy, and clinical applicability, this review aims to inform the optimization of TBM diagnostic strategies and explores the integration and clinical translation of multi-omics technologies.Keywords
This publication has 105 references indexed in Scilit:
- Single-cell analysis reveals changes in BCG vaccine-injected mice modeling tuberculous meningitis brain infectionCell Reports, 2023
- Comparative diagnostic utility of metagenomic next‐generation sequencing, GeneXpert, modified Ziehl–Neelsen staining, and culture using cerebrospinal fluid for tuberculous meningitis: A multi‐center, retrospective study in ChinaJournal of Clinical Laboratory Analysis, 2022
- Central nervous system and spinal cord tuberculosis: Revisiting an important diseaseClinical Imaging, 2021
- Reduction of Human DNA Contamination in Clinical Cerebrospinal Fluid Specimens Improves the Sensitivity of Metagenomic Next-Generation SequencingJournal of Molecular Neuroscience, 2020
- Intensified adjunctive corticosteroid therapy for CNS tuberculomasInfection, 2020
- Safety and Efficacy of Fludrocortisone in the Treatment of Cerebral Salt Wasting in Patients With Tuberculous MeningitisJAMA Neurology, 2018
- Mir-29a expressions in peripheral blood mononuclear cell and cerebrospinal fluid: Diagnostic value in patients with pediatric tuberculous meningitisBrain Research Bulletin, 2017
- Cerebrospinal fluid metabolomic profiling in tuberculous and viral meningitis: Screening potential markers for differential diagnosisClinica Chimica Acta, 2017
- Elevated host lipid metabolism revealed by iTRAQ-based quantitative proteomic analysis of cerebrospinal fluid of tuberculous meningitis patientsBiochemical and Biophysical Research Communications, 2015
- Tuberculous MeningitisJAMA, 1979